X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7%
Wed, 22 May

TORRENT PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

TORRENT PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m17,22020,51018,560-9.5%7.8%
Other incomeRs m42030170466.7%-59.5%
TurnoverRs m17,64020,54018,730-8.8%6.2%
ExpensesRs m13,58014,90013,830-7.2%1.8%
Gross profitRs m3,6405,6101,160-79.3%-68.1%
DepreciationRs m1,5101,5601,6002.6%6.0%
InterestRs m1,2101,3301,230-7.5%1.7%
Profit before taxRs m1,3402,750-1,500-154.5%-211.9%
TaxRs m-94029020-93.1%
Profit after taxRs m2,2802,460-1,520-161.8%-166.7%
Gross profit margin%21.127.46.3
Effective tax rate%-70.110.5-1.3
Net profit margin%12.912.0-8.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 7.8% on a year-on-year (YoY) basis. The expenses were up by 1.8% YoY during the same period.
  • The company's operating profit declined by 68.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 6.3% in 4QFY19 as against 21.1% in 4QFY18.
  • Depreciation charges increased by 6.0% and finance costs increased by 1.7% YoY, respectively.
  • Other income declined by 59.5% YoY during the quarter.
  • Net profit for the quarter declined by 166.7% YoY. Net profit margins during the quarter declined from 12.9% in 4QFY18 to -8.1% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 9.5% on a quarter-on-quarter (QoQ) basis. The expenses were down by 7.2% QoQ during the same period.
  • The company's operating profit declined by 79.3% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 6.3% in 4QFY19 as against 27.4% in 3QFY18.
  • Net profit for the quarter declined by 161.8% QoQ, while net profit margins declined from 12.0% in 3QFY18 to -8.1% in 4QFY19.

To see how TORRENT PHARMA has performed over the last eight quarters, please visit here.

TORRENT PHARMA Share Price Performance

Over the last one year, TORRENT PHARMA share price has moved up from Rs 1,337.4 to Rs 1,556.5, registering a Gain of Rs 219.2 or around 16.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,290.2 (up 0.2%). Over the last one year it has moved up from 12,829.5 to 13,290.2, a gain of 461 points (up 3.6%).

Overall, the S&P BSE SENSEX is up 13.1% over the year.

Current Valuations

At the current price of Rs 1,556.5, the price to earnings (P/E) ratio of TORRENT PHARMA stands at 60.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 5.7 times.

Equitymaster requests your view! Post a comment on "TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7%". Click here!

  

Related Views on News

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Jul 22, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - ADCOCK INGRAM COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS